Metabolic syndrome and rheumatic diseases

Terapevticheskii Arkhiv

Volumn 78, Issue 6, 2006, Pages 39-47

  Korochina, I E ^a   Bagirova, G G ^a  

^a NONE

Author keywords

Gout; Metabolic syndrome; Osteoarthrosis; Rheumatic diseases

Indexed keywords

CHOLESTEROL;

ADOLESCENT; ADULT; AGED; ARTICLE; BLOOD; DENSITOMETRY; DYSLIPIDEMIA; FEMALE; HOSPITALIZATION; HUMAN; HYPERTENSION; HYPERURICEMIA; MALE; MASS SCREENING; METABOLIC SYNDROME X; METHODOLOGY; MIDDLE AGED; OBESITY; PAIN; RHEUMATIC DISEASE;

ADOLESCENT; ADULT; AGED; CHOLESTEROL; DENSITOMETRY; DYSLIPIDEMIAS; FEMALE; HUMANS; HYPERTENSION; HYPERURICEMIA; MALE; MASS SCREENING; METABOLIC SYNDROME X; MIDDLE AGED; OBESITY; PAIN; RHEUMATIC DISEASES; SEVERITY OF ILLNESS INDEX;

EID: 33746811344     PISSN: 00403660     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (45)

1. Reaven G. M. Role of insulin resistance in human disease. Diabetes 1988; 37: 1595-1607.
2. Todaro J. F., Con A., Niaura R. et al. Combined effect of the metabolic syndrome and hostility on the incidence of myocardial infarction (the Normative Aging Study). Am. J. Cardiol. 2005; 96 (2): 221-226.
3. Milionis H. J., Liberopoulos E., Goudevenos J. et al. Risk factors of first-ever acute ischemic non-embolic stroke in elderly individuals. Int. J. Cardiol. 2005; 99 (2): 269-275.
4. Bang O. Y., Kim J. W., Lee J. H. et al. Association of the metabolic syndrome with intracranial atherosclerotic stroke. Neurology 2005; 65 (2): 296-298.
5. Niskanen L., Laakso M. Insulin resistance is related to albuminuria in patients with type II (non-insulin-dependent) diabetes mellitus. Metabolism 1993; 42 (12): 1541-1545.
6. Kario K., Nago N., Kayaba K. et al. Characteristics of the insulin resistance syndrome in a Japanese population. The Jichi Medical School Cohort Study. Arterioscler. Thromb. Vasc. Biol. 1996; 16 (2): 269-274.
7. Sattar N. Insulin resistance and the metabolic syndrome as predictors of cardiovascular risk: where are we now? Minerva Endocrinol. 2005; 30 (3): 121-138.
8. Caro J. Insulin resistance in obese and non obese man. J. Clin. Endocrinol. Metab. 1991; 73: 691-695.
9. Kaplan N. M. The deadly quartet: upper-body obesity, glucose intolerance, hypertriglyceridemia and hypertension. Arch. Intern. Med. 1989; 149 (7): 1514-1520.
10. Vasudevan A. R., Garber A. J. Insulin resistance syndrome. A review. Minerva Endocrinol. 2005; 30 (3): 101-119.
11. Anderson P. J., Critchley J. A., Chan J. C. et al. Factor analysis of the metabolic syndrome: obesity vs insulin resistance as the central abnormality. Int. J. Obes. Relat. Metab. Disord. 2001; 25 (12): 1782-1788.
12. Alberti K. G., Zimmet P. Z. for the WHO Consultation. Definition, diagnosis, and classification of diabetes mellitus and its complications, part I: diagnosis and classification of diabetes mellitus: provisional report of a WHO consultation. Diabet. Med. 1998; 15: 539-553.
13. New Definition of the Metabolic Syndrome [http://www.medscape.com/ viewarticle/504382?src = nldne].
14. Venugopal S. K., Devaraj S., Jialal I. Macrophage conditioned medium induces the expression of C-reactive protein in human aortic endothelial cells: potential for paracrine/autocrine effects. Am. J. Pathol. 2005; 166: 1265-1271.
15. Song Y., Ridker P. M., Manson J. E. et al. Magnesium intake, C-reactive protein, and the prevalence of metabolic syndrome in middle-aged and older U. S. women. Diabetes Care 2005; 28(6): 1438-1444.
16. Pai J. K., Pischon T., Ma J. et al. Inflammatory markers and the risk of coronary heart disease in men and women. N. Engl. J. Med. 2004; 351 (25): 2599-2610.
17. Nissen S. E., Tuzcu E. M., Schoenhagen P. et al. Stalin therapy, LDL cholesterol, C-reactive protein, and coronary artery disease. N. Engl. J. Med. 2005; 352 (1): 29-38.
18. Agmon Y., Khandheria B. K., Meissner I. et al. C-reactive protein and atherosclerosis of the thoracic aorta: a population-based transesophageal echocardiographic study. Arch. Intern. Med. 2004; 164 (16): 1781-1787.
19. Woodward M., Lowe G. D., Campbell D. J. et al. Associations of inflammatory and hemostatic variables with the risk of recurrent stroke. Stroke 2005; 36 (10): 2143-2147.
20. Bogaty P., Brophy J. M., Boyer L. et al. Fluctuating inflammatory markers in patients with stable ischemic heart disease. Arch. Intern. Med. 2005; 165 (2): 221-226.
21. Felson D. T. Relation of obesity and of vocational and avocational risk factors to osteoarthritis. J. Rheumatol. 2005; 32 (6): 1133-1135.
22. Terlain B., Dumond H., Presle N. et al. Is leptin the missing link between osteoarthritis and obesity? Ann. Pharm. Fr. 2005; 63 (3): 186-193.
23. Mirtz T. A., Greene L. Is obesity a risk factor for low back pain? An example of using the evidence to answer a clinical question. Chiropr. Osteopat. 2005; 13 (1): 2.
24. Denko C. W., Malemud C. J. Role of the growth hormone/insulin-like growth factor-1 paracrine axis in rheumatic diseases. Semin. Arthr. Rheum. 2005; 35 (1): 24-34.
25. Iwanaga H., Matsumoto T., Enomoto H. et al. Enhanced expression of insulin-like growth factor-binding proteins in human osteoarthritic cartilage detected by immunohistochemistry and in situ hybridization. Osteoarthr. Cartil. 2005; 13 (5): 439-448.
26. Mazzuca S. A., Brandt K. D., Schauwecker D. S. et al. Severity of joint pain and Kellgren-Lawrence grade at baseline are better predictors of joint space narrowing than bone scintigraphy in obese women with knee osteoarthritis. J. Rheumatol. 2005; 32 (8): 1540-1546.
27. Escalante A., Haas R. W., Rincon I. Paradoxical effect of body mass index on survival in rheumatoid arthritis: role of comorbidity and systemic inflammation. Arch. Intern. Med. 2005; 165 (14): 1624-1629.
28. Piechota G., Malkiewicz J., Karwat I. D. Obesity as a cause and result of disability. Przegl. Epidemiol. 2005; 59 (1): 155-161.
29. Chodosh J., Morton S. C., Mojica W. et al. Meta-analysis: chronic disease self-management programs for older adults. Ann. Intern. Med. 2005; 143 (6): 427-438.
30. Wetz H. H., Meffert R., Hafkemeyer U. Diabetic neuropathic osteoarthropathy of the knee joint. A rare but increasing complication - case report. Orthopäde 2004; 33 (9): 1026-1031.
31. Roubenoff R. Acquired immunodeficiency syndrome wasting, functional performance, and quality of life. Am. J. Manag. Care 2000; 6 (9): 1003-1016.